FDA Faulted for Working Improperly With Biogen Before Clearing Alzheimer’s Drug
https://www.wsj.com/articles/biogen-aduhelm-fda-approval-congressional-investigation-11672333482
Athenex HK Innovative Limited (Sha Tin, HK) Granted U.S. Patent #11,389,442 Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancer
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6674&f=G&l=50&d=PTXT&p=134&S1=20220719&OS=20220719&RS=20220719
Related Posts
Ford Refers BlueOval City As The ‘Blueprint’ For Its Electric Future; Says On Track With Construction
Ford Motor Co (NYSE:F) plans to produce 500,000 electric vehicles a year at its BlueOval City campus under construction in west…
American Lithium Corp Q4 EPS $(0.05) Vs $(0.03) Yoy; FY23 EPS $(0.17) Vs $(0.13) YoY
Year End
February 28, 2023
Year End
February 28, 2022
Loss and comprehensive loss
($34985,004)
($23,697,875)
Loss per share - basic and
PARTS iD Receives Notice Of Non-compliance From NYSE American
PARTS iD, Inc. (NYSE:ID) ("PARTS iD" or "the Company") today announced that it has received written notice (the "Notice") from the NYSE American LLC (the "NYSE American") stating that it is not in compliance with the